Hermetica Superfood Encyclopedia
The Short Answer
Ascophyllum nodosum extract contains a complex matrix of bioactive phlorotannins, fucoidans, laminarins, and alginic acid that collectively scavenge reactive oxygen species (ROS), modulate antioxidant enzyme activity, and inhibit key metabolic enzymes including alpha-amylase, alpha-glucosidase, and tyrosinase through concentration-dependent mechanisms. In vitro studies using intestinal cell models (Caco-2 and IPEC-J2) confirm dose-dependent ROS reduction, while sprout-application studies documented enzyme inhibition rates reaching 88.0% for tyrosinase and 84.92% for alpha-glucosidase at 0.01% extract concentration, though no human clinical trials currently validate these effects in vivo.
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary KeywordAscophyllum nodosum extract benefits

Norwegian Kelp Extract — botanical close-up
Health Benefits
**Antioxidant Activity**
Phlorotannins (PTs) and phenolic compounds in the extract neutralize reactive oxygen species (ROS) in a concentration-dependent manner; in vitro data show significant antioxidant capacity with IC50 reductions up to 70% in treated plant models and demonstrated ROS suppression in Caco-2 intestinal epithelial cells.
**Iodine Supply for Thyroid Function**
Ascophyllum nodosum is naturally rich in iodine, a mineral essential for synthesis of thyroid hormones T3 and T4; traditional coastal communities historically used brown seaweeds including this species as a dietary iodine source where terrestrial food iodine was scarce.
**Enzyme Inhibition Relevant to Metabolic Health**: At 0
01% concentration, the extract inhibited alpha-amylase by 67.16% ± 0.9 at 24 hours and alpha-glucosidase by 84.92% ± 1.2 at 36 hours in sprout models, suggesting potential relevance to postprandial glycemic modulation, though this remains unconfirmed in human trials.
**Anti-inflammatory Potential**
Fucoidan, a sulfated polysaccharide abundant in Ascophyllum nodosum, has been documented in broader seaweed literature to modulate NF-κB signaling pathways and reduce pro-inflammatory cytokine expression; the extract's reduction of oxidative stress in intestinal cell models also indirectly reflects anti-inflammatory capacity.
**Micronutrient Supplementation**
The extract delivers a broad spectrum of vitamins including B1, B2, B3, B6, B12, C, E, H (biotin), and K3, alongside minerals such as zinc and potassium and carotenoids like beta-carotene and fucoxanthin, offering a marine-sourced multivitamin-like nutritional profile.
**Skin and Cellular Health (Topical Use)**
Topical applications of Ascophyllum nodosum extract are used in cosmeceuticals for their ability to support cellular antioxidant defenses; phlorotannins and fucoxanthin are believed to modulate melanin synthesis via tyrosinase inhibition (up to 88.0% in vitro), relevant to skin-brightening formulations.
**Prebiotic and Gut-Supportive Properties**
Alginic acid, laminarin, and fucoidan function as soluble dietary fibers with prebiotic potential, selectively fermented by beneficial gut microbiota; this mechanism is under preliminary investigation for gut barrier integrity support, consistent with observed protective effects in intestinal cell models.
Origin & History

Natural habitat
Ascophyllum nodosum, commonly called knotted wrack or egg wrack, is a large, long-lived brown macroalga native to the cold, rocky intertidal zones of the North Atlantic Ocean, thriving along coastlines of Norway, Iceland, Ireland, the United Kingdom, and the northeastern coast of North America. It grows in sheltered, wave-protected shores attached to rocks via holdfasts, tolerating wide salinity and temperature fluctuations, and can live for decades, making it one of the most biomass-abundant seaweeds in its range. Commercial harvesting occurs primarily in Norway, Ireland, Canada, and the United States, where sustainable hand-cutting or mechanical harvesting practices are employed to supply the seaweed biostimulant, food, and nutraceutical industries.
“Brown seaweeds of the genus Ascophyllum have been harvested by coastal communities of Norway, Iceland, Scotland, Ireland, and Atlantic Canada for centuries, primarily as agricultural fertilizers and animal fodder rather than as formal medicinal agents, with records of use as soil amendments dating to at least the 17th century in the British Isles. In traditional Irish and Scottish coastal diets, wrack seaweeds including Ascophyllum nodosum were consumed directly and used in soups and broths as a natural iodine and mineral source, particularly in regions where dietary iodine deficiency was endemic, associating seaweed consumption with thyroid health outcomes in folk medicine. Scandinavian fishing communities historically fed dried Ascophyllum nodosum to livestock, particularly sheep and cattle, observing improvements in coat quality and reproductive health that modern researchers attribute to the iodine, zinc, and polyphenol content of the plant. The 20th century saw systematic scientific interest in Ascophyllum nodosum expand dramatically as the seaweed biostimulant industry grew, transitioning the species from a traditional subsistence resource to a globally traded commercial extract valued at hundreds of millions of dollars annually.”Traditional Medicine
Scientific Research
The current body of evidence for Ascophyllum nodosum extract in human health is limited almost exclusively to in vitro and agricultural/plant biostimulant studies, with no published human clinical trials identified in the available literature as of the current research review. In vitro work using intestinal cell lines (Caco-2 and IPEC-J2) provides mechanistic proof-of-concept for ROS reduction and cytoprotection under oxidative stress conditions, and sprout-application studies using Vigna radiata demonstrated statistically significant increases in total phenolic content (from 167.3 ± 8.1 to 308.4 ± 14.9 µg GAE/g) and robust enzyme inhibition (F-values of 10.879–19.1399, p<0.00001), indicating biologically active compounds with measurable effects. Agricultural field trials employing 4 treatment levels and 10 replications per treatment documented 19% increases in dry weight, 18.3% more leaves, and 30.44% higher phenolic content at 9 mL/L application rates (p≤0.05), though these outcomes reflect plant physiology rather than human pharmacology. The evidence base, while scientifically coherent and mechanistically plausible, remains at a preclinical stage, and translation of these findings to standardized human dosing, bioavailability, and clinical outcomes requires dedicated randomized controlled trials.
Preparation & Dosage

Traditional preparation
**Liquid Seaweed Extract (Agricultural/Biostimulant Grade)**
9 mL/L in plant studies; not standardized for human consumption; provided as concentrated liquid diluted prior to use
Applied at 0.01%–.
**Dried Whole Algae Powder**
Used in food and feed applications; typically encapsulated or blended; no standardized human clinical dose established.
**Water-Based Extract**
Yields low- to mid-molecular-weight phlorotannins with DP typically below 10; used in nutraceutical and cosmeceutical formulations for moderate antioxidant activity.
**Ethanol-Based Extract (Sephadex LH-20 purified)**
Yields higher-DP phlorotannins (DP 10–31) with superior in vitro antioxidant and enzyme inhibitory capacity; used in premium supplement and cosmeceutical applications.
**Fucoidan-Enriched Extract**
Isolated via hot water or acidic extraction followed by precipitation; concentration standardized to fucoidan content (commonly 40–85% fucoidan) in research-grade preparations.
**Traditional Dietary Use**
Whole dried seaweed consumed directly or as a broth ingredient in coastal Scandinavian, Irish, and North American cultures; no measured dose; consumed ad libitum as a food.
**Topical/Cosmeceutical Formulation**
Applied as 0.1%–5% w/w inclusion in creams, serums, or masks; no established minimum effective concentration validated in clinical dermatology trials.
**Dosing Note**
No regulatory body (FDA, EFSA) has established a Recommended Daily Intake (RDI) or tolerable upper limit for Ascophyllum nodosum extract specifically; iodine content necessitates caution with high-dose supplementation.
Nutritional Profile
Ascophyllum nodosum extract contains a diverse and concentrated array of bioactive compounds: polysaccharides including alginic acid (up to 40% dry weight in whole thallus), fucoidan (5–20% dry weight), and laminarin; phenolic compounds including phlorotannins with degrees of polymerization from 2 to 31 units depending on extraction solvent; carotenoids including fucoxanthin and beta-carotene; vitamins B1 (thiamine), B2 (riboflavin), B3 (niacin), B6 (pyridoxine), B12 (cobalamin), C (ascorbic acid), E (tocopherol), H (biotin), and K3 (menadione); and minerals with notable iodine content (up to 0.03–0.1% dry weight depending on seasonality and location), zinc, potassium, magnesium, calcium, and iron. The polyphenol bioavailability is influenced by molecular size and degree of polymerization, with lower-DP phlorotannins (water-extracted) demonstrating higher relative intestinal permeability compared to high-DP fractions; fucoidan bioavailability in humans is poorly characterized and likely requires partial depolymerization for systemic absorption. Iodine bioavailability from organic seaweed matrices is reported to be high (>70%) in general seaweed literature, raising particular attention to iodine dose management when using concentrated extracts.
How It Works
Mechanism of Action
Phlorotannins (PTs), the primary phenolic compounds in Ascophyllum nodosum, act as direct free radical scavengers by donating hydrogen atoms to neutralize ROS, with higher-degree-of-polymerization (DP) PTs obtained via ethanol extraction demonstrating superior antioxidant capacity compared to lower-DP water-extracted fractions. Fucoidans, sulfated polysaccharides, interfere with inflammatory signaling cascades by suppressing NF-κB pathway activation and modulating the expression of pro-inflammatory mediators, while laminarins interact with toll-like receptor 4 (TLR4) and beta-glucan receptors on immune cells to modulate innate immune responses. The extract's inhibition of alpha-amylase and alpha-glucosidase occurs through competitive or mixed-mode enzyme inhibition by phenolic compounds binding to the enzyme active sites, thereby slowing carbohydrate hydrolysis and blunting postprandial glucose release. Fucoxanthin, a marine carotenoid present in the extract, has been shown in broader literature to downregulate UCP1 expression in adipose tissue and inhibit MAPK/ERK signaling, contributing to antioxidant and potential anti-adipogenic effects, while iodine directly supports thyroid peroxidase-mediated organification reactions necessary for thyroid hormone biosynthesis.
Clinical Evidence
No human randomized controlled trials (RCTs) or controlled clinical trials investigating Ascophyllum nodosum extract as a nutritional supplement or therapeutic agent were identified in the current evidence base. Available data derive from in vitro cellular assays (Caco-2, IPEC-J2 models), plant growth experiments, and food crop antioxidant enhancement studies, none of which provide human pharmacokinetic, efficacy, or safety data. While the in vitro antioxidant and enzyme inhibition results are statistically significant and mechanistically coherent — with IC50 reductions up to 70% and glycosidase inhibition exceeding 84% at 0.01% concentration — these cannot be directly extrapolated to human supplemental dosing or therapeutic outcomes without clinical validation. Confidence in Ascophyllum nodosum extract for human health applications therefore remains low, and the ingredient should be classified as having preliminary preclinical evidence pending adequately powered human trials.
Safety & Interactions
At low dietary intake levels consistent with traditional seaweed consumption (whole dried seaweed as a minor food ingredient), Ascophyllum nodosum is generally regarded as safe; however, concentrated extracts can deliver pharmacologically significant iodine doses that may precipitate iodine-induced hyperthyroidism (Jod-Basedow phenomenon) or hypothyroidism, particularly in individuals with pre-existing thyroid disorders or autoimmune thyroid disease (Hashimoto's thyroiditis, Graves' disease). Individuals taking thyroid medications (levothyroxine, antithyroid drugs such as methimazole or propylthiouracil) should exercise caution, as high iodine intake can directly interfere with thyroid hormone synthesis and medication efficacy, potentially requiring dose adjustments under medical supervision. Fucoidan fractions carry theoretical anticoagulant activity based on structural similarity to heparin, raising concern for additive bleeding risk when co-administered with anticoagulant or antiplatelet drugs (warfarin, aspirin, clopidogrel, direct oral anticoagulants), though this interaction has not been confirmed in human pharmacokinetic studies for Ascophyllum nodosum specifically. Pregnancy and lactation guidance is absent from published literature; given the high iodine content and lack of human safety data for concentrated extracts, use during pregnancy should be restricted to culinary quantities and undertaken only under healthcare provider supervision, as excessive iodine during pregnancy is associated with fetal thyroid dysfunction.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ascophyllum nodosumKnotted WrackEgg WrackNorwegian KelpRockweed ExtractASNO extract
Frequently Asked Questions
What is Ascophyllum nodosum extract used for in supplements?
Ascophyllum nodosum extract is included in supplements primarily as a natural source of iodine to support thyroid hormone synthesis, and for its antioxidant phlorotannins and fucoidans that may reduce oxidative stress. It also provides a broad spectrum of vitamins (B12, C, E) and minerals (zinc, potassium). However, no human clinical trials have validated specific therapeutic dosing, so its use remains based on nutritional composition and preclinical evidence.
Is Ascophyllum nodosum extract safe to take daily?
At culinary quantities (equivalent to traditional dietary seaweed consumption), Ascophyllum nodosum is generally considered safe; however, concentrated extracts deliver high iodine levels that may disrupt thyroid function with daily use, particularly in individuals with thyroid disorders. People taking levothyroxine or antithyroid medications should consult a physician before supplementing, and those with Hashimoto's thyroiditis or Graves' disease face particular risk. No established human tolerable upper limit for the extract specifically exists as of current evidence.
How much iodine is in Ascophyllum nodosum extract?
Whole dried Ascophyllum nodosum thallus typically contains approximately 0.03–0.1% iodine by dry weight depending on season and harvest location. Concentrated extracts can therefore deliver substantial iodine doses that may approach or exceed the adult tolerable upper limit of 1,100 µg/day established by US and EU authorities. Consumers should check iodine content per serving on product labels and consult a healthcare provider, particularly if they have thyroid conditions.
Does Ascophyllum nodosum extract have clinical trial evidence for human health?
No human randomized controlled trials (RCTs) investigating Ascophyllum nodosum extract as a health supplement have been identified in the current scientific literature. Available evidence comes from in vitro cell studies (Caco-2 and IPEC-J2 intestinal cell lines) and agricultural plant studies, which demonstrate statistically significant antioxidant and enzyme inhibitory effects but cannot be directly translated to human clinical outcomes. The ingredient is therefore classified at a preliminary preclinical evidence level, and health claims require confirmation from adequately powered human trials.
What are phlorotannins in Ascophyllum nodosum and what do they do?
Phlorotannins (PTs) are a class of polyphenolic compounds unique to brown algae, formed by polymerization of phloroglucinol units, and are among the primary bioactive constituents of Ascophyllum nodosum extract. They function as potent antioxidants by donating hydrogen atoms to neutralize reactive oxygen species (ROS), and in vitro studies show they inhibit alpha-glucosidase and tyrosinase by binding enzyme active sites. Higher-degree-of-polymerization (DP) phlorotannins obtained via ethanol extraction exhibit superior antioxidant capacity compared to lower-DP water-extracted fractions, with DP values ranging from 2 to 31 reported in Ascophyllum nodosum.
Can Ascophyllum nodosum extract cause iodine overload or thyroid problems if taken long-term?
While Ascophyllum nodosum is rich in iodine and supports thyroid function, excessive iodine intake from any source can potentially trigger thyroid dysfunction in susceptible individuals, particularly those with existing thyroid conditions or autoimmune thyroid disease. Long-term use requires monitoring, especially for people already consuming iodized salt or other iodine-rich foods, to maintain iodine levels within the safe range of 100–400 mcg daily for adults. Consulting a healthcare provider before starting supplementation is recommended if you have a thyroid condition or take thyroid medications.
How does Ascophyllum nodosum extract compare to other seaweed extracts like kelp or Laminaria for antioxidant benefits?
Ascophyllum nodosum contains substantial phlorotannins and phenolic compounds that demonstrate strong in vitro antioxidant activity, similar to other brown seaweeds, though direct comparative studies on human bioavailability between species are limited. Kelp (Saccharina japonica) and Laminaria species also provide antioxidants and iodine but may differ in phlorotannin profiles and concentration; Ascophyllum nodosum is notably sustainably harvested and typically lower in heavy metals than some alternatives. The choice between seaweed extracts often depends on iodine content needs, sustainability practices, and individual tolerance rather than dramatically different efficacy.
Who should avoid Ascophyllum nodosum extract supplementation?
Individuals with hyperthyroidism, Graves' disease, thyroiditis, or those taking thyroid medications (especially levothyroxine) should avoid or carefully monitor Ascophyllum nodosum due to its high iodine content and potential to interfere with thyroid hormone balance. People with shellfish or iodine allergies may experience allergic reactions, and those on anticoagulant medications should consult a healthcare provider as brown seaweed compounds may have mild anticoagulant properties. Pregnant and breastfeeding women should seek medical guidance before use, as excess iodine exposure during these periods can affect fetal and neonatal thyroid development.

Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ascophyllum-nodosum-extract-ascophyllum-nodosum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)